Plasma hepatocyte growth factor and the relationship between risk factors and carotid atherosclerosis
- PMID: 12452316
- DOI: 10.1291/hypres.25.661
Plasma hepatocyte growth factor and the relationship between risk factors and carotid atherosclerosis
Abstract
Hepatocyte growth factor (HGF) has been shown to have a unique stimulating property on the endothelium as well as an anti-apoptotic action on the endothelium. Through these mechanisms, HGF has been shown to have an anti-atherogenic action in animal models. In atherosclerotic disorders, the circulating level of HGF has been shown to be increased to compensate for its decline in tissue. However, whether increased circulating HGF has any influence on the development of atherosclerosis has not been elucidated. In the present study, the association between plasma HGF concentration and the risk factor-carotid atherosclerosis relationship was evaluated. Three hundred and seventeen community-dwelling subjects participated in the study. The plasma concentration of HGF was determined by enzyme-linked immunosorbent assay (ELISA). The subjects were divided into two groups according to the plasma level of HGF: a low HGF group (n=199, plasma HGF < 150 pg/ml) and a high HGF group (n=118, plasma HGF > or = 150 pg/ml). Risk factors for atherosclerosis were evaluated in each subject. Carotid ultrasonography was performed to measure carotid arterial intima-media thickness (IMT) and the presence of plaque. The association between carotid IMT and risk factors was then evaluated in the two HGF groups. The regression lines between age and carotid IMT were significantly different between the low HGF and high HGF groups (F[1,313]=5.98, p=0.015). The regression lines between systolic blood pressure and carotid IMT were also significantly different between the two HGF groups (F[1,313]=5.17, p=0.024). A general linear model showed that the interaction between age and plasma level of HGF was significantly associated with carotid IMT, suggesting that the plasma level of HGF modifies the age-related increase in carotid IMT. In addition, clustering of risk factors was evaluated in subjects with carotid atherosclerosis. The number of total risk factors in carotid atherosclerosis subjects with high plasma HGF was significantly greater than that in those with low HGF, even though the two groups had a similar magnitude of carotid atherosclerosis. In conclusion, these findings indicate that risk factor-dependent augmentation of carotid atherosclerosis could be influenced by circulating HGF.
Similar articles
-
Association between carotid arterial remodeling and plasma concentration of circulating hepatocyte growth factor.J Hypertens. 2001 Nov;19(11):1975-9. doi: 10.1097/00004872-200111000-00007. J Hypertens. 2001. PMID: 11677362
-
Significance of serum circulating hepatocyte growth factor in the development of carotid atherosclerosis.J Atheroscler Thromb. 2003;10(3):154-9. doi: 10.5551/jat.10.154. J Atheroscler Thromb. 2003. PMID: 14564084
-
Factors associated with carotid atherosclerosis in community-dwelling oldest elderly aged over 80 years.Geriatr Gerontol Int. 2008 Mar;8(1):12-8. doi: 10.1111/j.1447-0594.2008.00441.x. Geriatr Gerontol Int. 2008. PMID: 18713184
-
Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes.Diabet Med. 2006 Jun;23(6):617-22. doi: 10.1111/j.1464-5491.2006.01849.x. Diabet Med. 2006. PMID: 16759302
-
Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.World J Diabetes. 2014 Oct 15;5(5):678-88. doi: 10.4239/wjd.v5.i5.678. World J Diabetes. 2014. PMID: 25317245 Free PMC article. Review.
Cited by
-
Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: results from the Women's Health Initiative.Stroke. 2010 May;41(5):857-62. doi: 10.1161/STROKEAHA.109.567719. Epub 2010 Mar 4. Stroke. 2010. PMID: 20203323 Free PMC article.
-
Circulating Hepatocyte Growth Factor Reflects Activation of Vascular Repair in Response to Stress.JACC Basic Transl Sci. 2022 Jul 20;7(8):747-762. doi: 10.1016/j.jacbts.2022.03.013. eCollection 2022 Aug. JACC Basic Transl Sci. 2022. PMID: 36061342 Free PMC article.
-
Hepatocyte growth factor and carotid intima-media thickness in relation to circulating CD34-positive cell levels.Environ Health Prev Med. 2018 May 3;23(1):16. doi: 10.1186/s12199-018-0705-4. Environ Health Prev Med. 2018. PMID: 29724162 Free PMC article.
-
Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.Heart. 2017 Aug;103(15):1185-1193. doi: 10.1136/heartjnl-2016-310450. Epub 2017 Jun 1. Heart. 2017. PMID: 28572400 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical